Process for development-processing silver halide light-sensitive material
    31.
    发明授权
    Process for development-processing silver halide light-sensitive material 失效
    卤化银感光材料开发处理工艺

    公开(公告)号:US4391900A

    公开(公告)日:1983-07-05

    申请号:US339243

    申请日:1982-01-13

    IPC分类号: G03C5/29 G03C5/305 G03C5/30

    CPC分类号: G03C5/305

    摘要: A process for development-processing a silver halide photographic light-sensitive material is described, comprising processing with a developing solution containing 0.1 mol/liter or more of sulfite ion and at least one compound represented by formula (I) ##STR1## wherein n represents an integer of from 2 to 6; each of R.sub.1 and R.sub.2 represents hydrogen or an alkyl group having from 1 to 6 carbon atoms; and M represents hydrogen or an alkali metal atom.According to the process, the generation of silver sludge and the formation of fog are prevented when a black-and-white photographic light-sensitive material is processed with a developing solution containing sulfates in a high concentration.

    摘要翻译: 描述了一种用于显影处理卤化银照相感光材料的方法,包括用含有0.1mol / l或更多的亚硫酸根离子的显影溶液和至少一种由式(I)表示的化合物(I) 其中n表示2至6的整数; R 1和R 2各自表示氢或具有1至6个碳原子的烷基; M表示氢或碱金属原子。 根据该方法,当用含有高浓度硫酸盐的显影液处理黑白照相感光材料时,可防止银污泥的产生和雾的形成。

    Color photographic light-sensitive elements containing anti-color
fogging agents
    32.
    发明授权
    Color photographic light-sensitive elements containing anti-color fogging agents 失效
    彩色摄影感光元素含有防着色剂

    公开(公告)号:US4232114A

    公开(公告)日:1980-11-04

    申请号:US939108

    申请日:1978-09-01

    摘要: A color photographic light-sensitive element having (1) reduced fog, (2) low reduction in sensitivity and (3) good yellow dye image light fastness, and comprising a support having thereon at least one silver halide photographic emulsion and optionally one or more non-light-sensitive subsidiary layers, wherein a blue-sensitive silver halide photographic emulsion layer and/or a non-light-sensitive layer adjacent thereto contains at least one asymmetrical hydroquinone compound selected from the group consisting of 2-methyl-5-tert-octylhydroquinone, 2-tert-butyl-5-tert- amylhydroquinone, 2-tert-butyl-5-tert-hexylhydroquinone, 2-methyl-5-tert-hexylhydroquinone, 2-methyl-5-tert-amylhydroquinone, 2-methyl-5-(1'-methylcyclohexyl)hydroquinone and precursors thereof wherein either or both hydroxyl groups are modified with an acyl group represented by the formulae: ##STR1## wherein R represents an alkyl group.

    摘要翻译: 一种彩色照相感光元件,其具有(1)减雾,(2)灵敏度降低低,(3)黄色染料图像耐光性良好,并且包括其上具有至少一种卤化银照相乳剂和任选的一种或多种 非敏感性辅助层,其中感蓝卤化银照相乳剂层和/或与其相邻的非感光层含有至少一种不对称氢醌化合物,其选自2-甲基-5-叔 2-叔丁基-5-叔戊基氢醌,2-叔丁基-5-叔己基氢醌,2-甲基-5-叔己基氢醌,2-甲基-5-叔戊基氢醌,2-甲基-5-叔己基氢醌,2-甲基-5-叔己基氢醌, -5-(1'-甲基环己基)氢醌及其前体,其中羟基之一或两者用下式表示的酰基进行改性:其中R表示烷基。

    Developing a silver ha1ide emulsion in contact with a heterocyclic
thione and a polyalkylene oxide
    34.
    发明授权
    Developing a silver ha1ide emulsion in contact with a heterocyclic thione and a polyalkylene oxide 失效
    开发一种与异戊二烯和一种聚氧乙烯氧化物接触的银HAIIDE乳液

    公开(公告)号:US4001020A

    公开(公告)日:1977-01-04

    申请号:US548843

    申请日:1975-02-10

    IPC分类号: G03C1/043 G03C1/34 G03C5/20

    CPC分类号: G03C1/043 G03C1/346

    摘要: A method for forming photographic images of particularly improved sharpness in which a photographic element is developed in the presence of an alkylene oxide polymer and a compound of the general formula ##STR1## wherein Q represents the atoms required to form an optionally substituted, defined heterocyclic ring and R is as defined in the specification, or a compound of the general formula ##STR2## wherein W is a sulfur, selenium or oxygen atom or a group >N--R.sub.3, R.sub.1, R.sub.2, and R.sub.3 each is an optionally substituted, defined alkyl group and Z represents the atoms required to form an optionally substituted, defined heterocyclic ring.

    Composition and method for treating cancer
    36.
    发明授权
    Composition and method for treating cancer 失效
    用于治疗癌症的组合物和方法

    公开(公告)号:US5861424A

    公开(公告)日:1999-01-19

    申请号:US478582

    申请日:1995-06-07

    摘要: A pharmaceutical composition for treatment of cancer in a mammal comprising:(A) a therapeutically effective amount of at least one compound selected from the group consisting of compounds represented by the General Formulas (1) to (6) ##STR1## wherein X.sub.1 is O, S, Se, or >N--R.sub.14, ##STR2## X.sub.2 is O, S, Se, >N--R.sub.15, X.sub.3 is O, S, Se, ##STR3## X.sub.4 is >N--R.sub.19, or Y.sub.1 is O, S, Se, or >N--R.sub.18 ;Z.sub.1 represents an atomic group necessary to form a saturated or unsaturated 5- or 6-membered ring which may be substituted or may have another ring fused therewith;Z.sub.2 is a naphthalene ring, an anthracene ring or a phenanthrene ring which may be substituted; in combination with(B) a pharmaceutically acceptable carrier or diluent; and a method for treatment of cancer comprising administering the above pharmaceutical composition to a host afflicted with cancer.

    摘要翻译: 一种用于治疗哺乳动物癌症的药物组合物,包括:(A)治疗有效量的至少一种选自由通式(1)至(6)表示的化合物的化合物。 (2)(3)(4)

    Anti-cancer composition comprising rhodacyanine compound and cyclodextrin
    37.
    发明授权
    Anti-cancer composition comprising rhodacyanine compound and cyclodextrin 失效
    抗癌组合物,其含有花青素化合物和环糊精

    公开(公告)号:US5670530A

    公开(公告)日:1997-09-23

    申请号:US474974

    申请日:1995-06-07

    摘要: An anti-cancer composition comprising a rhodacyanine compound and cyclodextrin or derivative thereof, wherein said rhodacyanine compound is selected from the group consisting of compounds represented by the following Formula (I), the cation moiety of which has a log P value of 4.5-12: ##STR1## wherein X.sub.1 and X.sub.2, which may be the same or different, each represents O, S, Se, ##STR2## Y.sub.1 represents O, S, Se, or ##STR3## R.sub.1 and R.sub.3, which may be the same or different, each represents an alkyl group; R.sub.2 represents an alkyl group, an aryl group or a heterocyclic group; Z.sub.1 and Z.sub.2, which may be the same or different, each represents an atomic group necessary to form a 5- or 6-membered ring; L.sub.1, L.sub.2 and L.sub.3, which may be the same or different, each represents a methine group or nitrogen atom and L.sub.1 and R.sub.3 may combine and form a 5- or 6-membered ring; R.sub.4 and R.sub.5, which may be the same or different, each represents an alkyl group; R.sub.6 and R.sub.7, which may be the same or different, each represents an alkyl group or an aryl group; Q represents a pharmaceutically acceptable anion; j and k, which may be the same or different, each represents 1 or 2; m and n, which may be the same or different, each represents 0 or 1.

    摘要翻译: 一种抗癌组合物,其含有多花青素化合物和环糊精或其衍生物,其中所述的萝沙星化合物选自由下式(I)表示的化合物,其阳离子部分的log P值为4.5-12 其中X1和X2可以相同或不同,分别表示O,S,Se,Y1表示O,S,Se或者R1,R3, 其可以相同或不同,各自表示烷基; R2表示烷基,芳基或杂环基; Z 1和Z 2可以相同或不同,表示形成5-或6-元环所必需的原子团; L1,L2和L3可以相同或不同,表示次甲基或氮原子,L1和R3可以结合形成5-或6-元环; R 4和R 5可以相同或不同,各自表示烷基; R 6和R 7可以相同或不同,各自表示烷基或芳基; Q表示药学上可接受的阴离子; j和k可以相同或不同,各自表示1或2; m和n可以相同或不同,各自表示0或1。

    Silver halide photographic materials

    公开(公告)号:US4923794A

    公开(公告)日:1990-05-08

    申请号:US378100

    申请日:1989-07-11

    IPC分类号: G03C1/34 G03C1/043

    CPC分类号: G03C1/043

    摘要: A silver halide photographic material comprising silver halide emulsion including a telluroether compound of the formula (I):L.sub.1 --Te--L.sub.2 (I)wherein L.sub.1 and L.sub.2 each independently represents a substituted or unsubstituted aliphatic group which is substituted with at least one hydroxyl group, mercapto group, amino group, ether group, selenoether group, thioether group, ammonium group, sulfonyl group, carbamoyl group, carbonamido group, sulfamoyl group, sulfonamido group, acyloxy group, sulfonyloxy group, ureido group, thioureido group, thioamido group, oxysulfonyl group, oxycarbonylamino group, sulfonic acid group or salt thereof, phosphoric acid or salt thereof, phosphoric ester group, sulfinic acid group or a salt thereof, phosphino group or heterocyclic group.